These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22406118)

  • 1. Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.
    Jia Q; Jiang X; Yu F; Qiu J; Kang X; Cai L; Li L; Shi W; Liu S; Jiang S; Liu K
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2393-5. PubMed ID: 22406118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1.
    Congote LF
    Biochem Biophys Res Commun; 2006 May; 343(2):617-22. PubMed ID: 16554023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serpin A1 and CD91 as host instruments against HIV-1 infection: are extracellular antiviral peptides acting as intracellular messengers?
    Congote LF
    Virus Res; 2007 May; 125(2):119-34. PubMed ID: 17258834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J; Ständker L; Adermann K; Schulz A; Schindler M; Chinnadurai R; Pöhlmann S; Chaipan C; Biet T; Peters T; Meyer B; Wilhelm D; Lu H; Jing W; Jiang S; Forssmann WG; Kirchhoff F
    Cell; 2007 Apr; 129(2):263-75. PubMed ID: 17448989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
    Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
    Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M; Baranyi L; Okada N; Okada H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.
    Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C
    Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
    Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
    J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-AIDS agents. Part 58: synthesis and anti-HIV activity of 1-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (1-thia-DCK) analogues.
    Xia P; Yin ZJ; Chen Y; Zhang Q; Zhang B; Xia Y; Yang ZY; Kilgore N; Wild C; Morris-Natschke SL; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3341-3. PubMed ID: 15149703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
    Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
    Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.
    Lu RJ; Tucker JA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Pickens J; Tandel S; Brahmachary E; Yang Y; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Khasanov A; Ma YA; Jeffries C; Liu C; Proskurina T; Zhu T; Chucholowski A; Li R; Sexton C
    J Med Chem; 2007 Dec; 50(26):6535-44. PubMed ID: 18052117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
    Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
    Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of novel acyclic versions of Neplanocin A.
    Wu Y; Hong JH
    Arch Pharm (Weinheim); 2005 Nov; 338(11):517-21. PubMed ID: 16281309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.